This poster presentation is under embargo until 20 April 2026, as per congress regulations.

Please subscribe using the button below to receive a notification when the material becomes available:​

Register for email alerts 

Publication
  • WFH •
  • 20 April, 2026 •
  • •

Physical Activity and Bleed Prevention for People With Severe Haemophilia A Treated With Once-Weekly Efanesoctocog Alfa: A Plain-Language Summary of 12-Month Interim Results From the FREEDOM Study

Ana Boban, Kate Talks, Irena Preložnik Zupan, Paul Van der Valk, Josefin Blomkvist, Elena Santagostino, Markus Fusser, Jan Astermark

Publication
  • WFH •
  • 20 April, 2026 •
  • •

Joint Health Outcomes with Efanesoctocog Alfa in Adults/Adolescents from XTEND-1 Continuing in XTEND-ed: Plain Language Summary

Christoph Königs, Annette von Drygalski, Cedric Hermans, Barbara A. Konkle, Paul Van der Valk, Liane Khoo, Nobuaki Suzuki, Liqi Feng, Umer Khan, Linda Bystrická, Jennifer Dumont, Elena Santagostino, Lara Mamikonian, Robert Klamroth

Publication
  • WFH •
  • 20 April, 2026 •
  • •

Plain Language Summary: What is Extravascular Distribution of Factor IX and how does it Affect Management of Those with Haemophilia B?

Cedric Hermans, Carmen Escuriola Ettingshausen, Michael Laffan, Davide Matino, Niamh O’Connell, Robert Sidonio, Rolf Ljung

Sign up for alerts